STRC SE

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, STRC SE has already paid €0.12 in dividends. The last payout was in July.

Financials

In the last quarter, STRC SE had revenue of €59.11M and net profit of €4.16M

(EUR)	June 2026	YoY
Revenue	59.11M	0.31%
Gross profit	15.24M	4.62%
Net profit	4.16M	219.91%
EBITDA	10.15M	39.76%

Fundamentals

Metric	Value
Market capitalization	€1.5B
Number of shares	303.9M
52-week high/low	€5.16 - €4.47
Dividend yield	0.54%
Dividends TTM	€0.12
Beta	0.86
P/E ratio	-598.75
PEG ratio	9.20
P/B ratio	1.22
P/S ratio	1.19

Company profile

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.